Moreover, DR5 has also been found to be upregulated in esculetin-treated cancer cells that consequently resulted in the sensitization of oral cancer cells to TRAIL-induced signals [17]. The gene discussed is TNFRSF10B; the disease is lip and oral cavity carcinoma.